BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/24/2021 9:54:22 AM | Browse: 750 | Download: 1798
 |
Received |
|
2021-02-25 17:16 |
|
Peer-Review Started |
|
2021-02-25 17:31 |
|
First Decision by Editorial Office Director |
|
2021-05-03 00:26 |
|
Return for Revision |
|
2021-05-03 00:26 |
|
Revised |
|
2021-05-06 13:28 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-10-08 03:30 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-10-11 01:19 |
|
Articles in Press |
|
2021-10-11 01:19 |
|
Edit the Manuscript by Language Editor |
|
2021-09-30 13:20 |
|
Typeset the Manuscript |
|
2021-11-19 01:03 |
|
Publish the Manuscript Online |
|
2021-11-24 09:54 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Liver involvement in inflammatory bowel disease: What should the clinician know?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Giuseppe Losurdo, Irene Vita Brescia, Chiara Lillo, Martino Mezzapesa, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo and Maria Rendina |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Giuseppe Losurdo, MD, Doctor, Doctor, Section of Gastroenterology, Department of Emergency and Organ Transplantation, University of Bari, Pzza Giulio Cesare, Bari 70124, Italy. giuseppelos@alice.it |
| Key Words |
Inflammatory bowel disease; Liver; Primary sclerosing cholangitis; Viral hepatitis; Immunosuppression; Non-alcoholic fatty liver disease |
| Core Tip |
In the present article, several aspects of liver involvement of inflammatory bowel disease (IBD) have been highlighted. Co-occurrence of primary sclerosing cholangitis is one of the most well-known comorbidities and deserves more attention by the clinician. Liver damage due to drugs used to cure IBD is also a relevant issue. Finally, some emerging topics such as the spread of liver steatosis or the implications of chronic viral hepatitis have been analyzed. |
| Publish Date |
2021-11-24 09:54 |
| Citation |
Losurdo G, Brescia IV, Lillo C, Mezzapesa M, Barone M, Principi M, Ierardi E, Di Leo A, Rendina M. Liver involvement in inflammatory bowel disease: What should the clinician know? World J Hepatol 2021; 13(11): 1534-1551 |
| URL |
https://www.wjgnet.com/1948-5182/full/v13/i11/1534.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v13.i11.1534 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
